$391 Million is the total value of 5AM Venture Management, LLC's 24 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 33.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | ENLIVEN THERAPEUTICS INC | $126,986,603 | – | 5,798,475 | +100.0% | 32.47% | – | |
ENTRADA THERAPEUTICS INC | $63,921,496 | +7.2% | 4,408,379 | 0.0% | 16.35% | +2.1% | ||
VOR | VOR BIOPHARMA INC | $34,226,070 | -19.1% | 6,361,723 | 0.0% | 8.75% | -23.0% | |
Sell | RALLYBIO CORP | $20,731,434 | -15.4% | 3,630,724 | -2.7% | 5.30% | -19.5% | |
CRNX | CRINETICS PHARMACEUTICALS IN | $13,848,313 | -12.2% | 862,286 | 0.0% | 3.54% | -16.5% | |
DISC MEDICINE INC | $12,469,086 | +6.5% | 588,442 | 0.0% | 3.19% | +1.4% | ||
IDYA | Sell | IDEAYA BIOSCIENCES INC | $11,924,780 | -45.1% | 868,520 | -27.4% | 3.05% | -47.8% |
SCPH | Sell | SCPHARMACEUTICALS INC | $10,889,868 | -44.5% | 1,200,647 | -56.1% | 2.78% | -47.2% |
FGEN | Buy | FIBROGEN INC | $10,812,238 | +199.2% | 579,434 | +156.9% | 2.76% | +184.8% |
RNA | AVIDITY BIOSCIENCES INC | $10,216,269 | -30.8% | 665,555 | 0.0% | 2.61% | -34.2% | |
ARVN | ARVINAS INC | $8,742,400 | -20.1% | 320,000 | 0.0% | 2.24% | -24.0% | |
COGT | COGENT BIOSCIENCES INC | $8,528,848 | -6.7% | 790,440 | 0.0% | 2.18% | -11.2% | |
ANAB | ANAPTYSBIO INC | $7,784,270 | -29.8% | 357,733 | 0.0% | 1.99% | -33.2% | |
VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $7,123,200 | -18.7% | 280,000 | -6.7% | 1.82% | -22.6% |
ISEE | Sell | IVERIC BIO INC | $6,924,951 | -15.9% | 284,626 | -26.0% | 1.77% | -20.0% |
VKTX | New | VIKING THERAPEUTICS INC | $5,827,500 | – | 350,000 | +100.0% | 1.49% | – |
SPRB | New | SPRUCE BIOSCIENCES INC | $5,224,440 | – | 2,364,000 | +100.0% | 1.34% | – |
MRSN | New | MERSANA THERAPEUTICS INC | $4,870,350 | – | 1,185,000 | +100.0% | 1.24% | – |
PHVS | PHARVARIS N V | $4,733,118 | -28.4% | 587,600 | 0.0% | 1.21% | -31.9% | |
FIXX | HOMOLOGY MEDICINES INC | $4,671,997 | -18.3% | 4,535,919 | 0.0% | 1.20% | -22.2% | |
PEAR THERAPEUTICS INC | $4,269,749 | -78.4% | 16,744,113 | 0.0% | 1.09% | -79.4% | ||
IMPL | IMPEL PHARMACEUTICALS INC | $4,038,707 | -62.7% | 2,884,791 | 0.0% | 1.03% | -64.5% | |
CDTX | CIDARA THERAPEUTICS INC | $1,440,829 | +67.9% | 1,134,511 | 0.0% | 0.37% | +59.3% | |
New | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $831,130 | – | 38,856 | +100.0% | 0.21% | – | |
JANX | Exit | JANUX THERAPEUTICS INC | $0 | – | -446,266 | -100.0% | -1.58% | – |
Exit | CINCOR PHARMA INC | $0 | – | -4,937,646 | -100.0% | -16.31% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
HOMOLOGY MEDICINES INC | 16 | Q3 2023 | 26.6% |
ARVINAS INC | 16 | Q3 2023 | 14.3% |
Crinetics Pharmaceuticals, Inc. | 16 | Q3 2023 | 12.8% |
SCPHARMACEUTICALS INC | 16 | Q3 2023 | 7.5% |
CIDARA THERAPEUTICS INC | 16 | Q3 2023 | 1.7% |
IDEAYA BIOSCIENCES INC | 14 | Q1 2023 | 11.4% |
VOR BIOPHARMA INC | 11 | Q3 2023 | 51.9% |
CABALETTA BIO INC | 11 | Q2 2022 | 14.2% |
AKOUOS INC | 10 | Q3 2022 | 27.7% |
IMPEL PHARMACEUTICALS INC | 10 | Q3 2023 | 7.1% |
View 5AM Venture Management, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-03 |
13F-HR | 2021-11-15 |
View 5AM Venture Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.